Overview

This trial is active, not recruiting.

Conditions aging, physical functioning, cognitive functioning, fitness
Treatment biomarker studies
Sponsor Duke University
Start date May 2012
End date December 2016
Trial size 1000 participants
Trial identifier NCT01720472, Pro00036608

Summary

The purpose of this study is to use the MURDOCK Horizon 1.5 infrastructure (Duke Instutional Review Board Pro00011196) to specifically target and enroll 1,000 participants across age groups and other demographic categories in order to develop a diverse cohort with specific physical and cognitive performance data paired with biological samples.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
Arm
biomarker studies

Primary Outcomes

Measure
Implementing a Physical and Cognitive Performance Assessment Cohort in the MURDOCK Study Community Registry and Biorepository
time frame: Upto 2 years or 24 months

Eligibility Criteria

Male or female participants at least 30 years old.

Inclusion Criteria: - A resident of Cabarrus County and/or the city of Kannapolis (and surrounding regions) or certain portions of Rowan, Mecklenburg, or Stanly counties in North Carolina for 6 or more months of the year. - Age 30 or older Exclusion Criteria: - Female that is currently pregnant - Having had a heart attack, angina, congestive heart failure, or fluid in the lungs within the past 6 months - Participant that requires consent by a legally authorized representative - Participant that cannot walk 30ft without human assistance

Additional Information

Official title Implementing a Physical and Cognitive Performance Assessment Cohort in the MURDOCK Study Community Registry and Biorepository
Principal investigator Miriam C Morey, Ph.D.
Description The MURDOCK Study, proposes this Horizon 2 study to collect a brief physical and cognitive performance assessment from 1,000 MURDOCK Registry participants. Blood sample aliquots will also be obtained. These physical and cognitive performance data, paired with -omics data from plasma and serum sample analyses, offer promise in the discovery of biomarkers for functional decline. This research will provide an important basis for our understanding of the physical, lifestyle, and genetic factors which, over the lifespan, contribute to changes in physical and cognitive capabilities as we age.
Trial information was received from ClinicalTrials.gov and was last updated in August 2016.
Information provided to ClinicalTrials.gov by Duke University.